Matrix and diseases of the CNS

Trends in Neurosciences

Volumn 21, Issue 2, 1998, Pages 75-80

  Yong, Voon Wee ^a   Krekoski, Craig A ^a   Forsyth, Peter A ^a   Bell, Robert ^a   Edwards, Dylan R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE;

ALZHEIMER DISEASE; ANGIOGENESIS; CANCER INVASION; DEMYELINATION; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; METASTASIS POTENTIAL; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0032006878     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(97)01169-7     Document Type: Review

References (50)

1. 1 Van Wart, H.E. and Birkedal-Hansen, H. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 5578-5582
2. 2 Murphy, G. and Knauper, V. (1997) Matrix Biol. 15, 511-518
3. 3 Edwards, D.R. et al. (1996) Int. J. Obes. 20 (Suppl. 3), S9-S15
4. 4 Edwards, D.R. et al. (1987) EMBO J. 6, 1899-1904
5. 5 Lacraz, S. et al. (1995) J. Clin. Invest. 96, 2304-2310
6. 6 Cuzner, M.L. et al. (1978) Ann. Neurol. 4, 337-344
7. 7 Opdenakker, G. and Van Damme, J. (1994) Immunol. Today 15, 103-107
8. 8 Maeda, A. and Sobel, R.A. (1996) Exp. Neurol. 55, 300-309
9. 9 Cuzner, M.L. et al. (1996) J. Neuropathol. Exp. Neurol. 55, 1194-1204
10. 10 Clements, J.M. et al. (1997) J. Neuroimmunol. 74, 85-94
11. 11 Gottschall, P.E. and Deb, S. (1996) Neuroimmunomodulation 3, 69-75
12. 12 Apodaca, G. et al. (1990) Cancer Res. 50, 2322-2329
13. 13 Colton, C.A. et al. (1993) J. Neurosci. Res. 35, 297-304
14. 14 Uhm, J.H. et al. Glia (in press)
15. 15 Brosnan, C.F. et al. (1980) Nature 285, 235-237
16. 16 Gijbels, K. et al. (1994) J. Clin. Invest. 94, 2177-2182
17. 17 Hewson, A.K. et al. (1995) Inflammation Res. 44, 45-49
18. 18 Chandler, S. et al. (1997) J. Neuroimmunol. 72, 155-161
19. 19 Stuve, O. et al. (1996) Ann. Neurol. 40, 853-863
20. 20 Leppert, D. et al. (1995) J. Immunol. 154, 4379-4389
21. 21 Leppert, D. et al. (1996) Ann. Neurol. 40, 846-852
22. 22 Moss, M.L. et al. (1997) Nature 385, 733-736
23. 23 Black, R.A. et al. (1997) Nature 385, 729-733
24. 24 Rosenberg, G.A. et al. (1992) Brain Res. 576, 203-207
25. 25 Matyszak, M.K. and Perry, V.H. (1996) J. Neuroimmunol. 69, 141-149
26. 26 Selkoe, D.J. (1994) Annu. Rev. Cell Biol. 10, 373-403
27. 27 Deb, S. et al. (1996) J. Neurochem. 66, 1641-1647
28. 28 Backstrom, J.R. et al. (1992) J. Neurochem. 58, 983-992
29. 29 Miyazaki, K. et al. (1993) Nature 362, 839-841
30. 30 Roher, A.E. et al. (1994) Biochim. Biophys. Res. Commun. 205, 1755-1761
31. 31 LePage, R.N. et al. (1995) FEBS Lett. 377, 267-270
32. 32 Evin, G. et al. (1994) Int. J. Exp. Clin. Invest. 1, 263-280
33. 33 Walsh, D.M. et al. (1994) Nature 367, 27-28
34. 34 Peress, N. et al. (1995) Exp. Neurol. 54, 16-22
35. 35 Stetler-Stevenson, W.G. et al. (1993) Annu. Rev. Cell. Biol. 9, 541-573
36. 36 Matuzawa, K. et al. (1996) J. Neuropathol. Exp. Neurol. 55, 88-96
37. 37 Heppner, K.J. et al. (1996) Am. J. Pathol. 149, 273-282
38. 38 Yamamoto, M. et al. (1996) Cancer Res. 56, 384-392
39. 39 Rao, J.S. et al. (1996) Clin. Exp. Metastasis 14, 12-18
40. 40 Uhm, J.H. et al. (1996) Clin. Exp. Metastasis 14, 421-433
41. 41 Forsyth, P.F. et al. J. Neuro-Oncol. (in press)
42. 42 Mohanam, S. et al. (1995) Clin. Exp. Metastasis 13, 57-62
43. 43 Yamashita, K. et al. (1996) FEBS Lett. 396, 103-107
44. 44 Uhm, J.H. et al. (1997) Can. J. Neurol Sci. 24, 3-15
45. 45 Rosenberg, G.A. and Navratil, M. (1997) Neurology 48, 921-926
46. 46 Lim, G.P. et al. (1996) J. Neurochem. 67, 251-259
47. 47 La Fleur, M. et al. (1996) J. Exp. Med. 184, 2311-2326
48. 48 Bertolotto, A. et al. (1990) J. Neurol. Sci. 100, 113-123
49. 49 Amberger, V.R. et al. (1997) Eur. J. Neurosci. 9, 151-162
50. 50 Nordstrom, L.A. et al. (1995) Mol. Cell. Neurosci. 6, 56-68